- Resources
Advair Vs. Serevent
Researchers at Santa Clara Medical Center have found that patients
who take Advair and Serevent to control asthma have nearly triple
the risk of asthma-related death compared to placebo. The data
review, which included nearly 34,000 patients, also found that
those taking the drugs experienced more asthma-related
hospitalizations than those taking a placebo.
More information on "Advair Vs. Serevent"
From Our Experts
Serevent and Foradil: Why Aren’t They Worried About COPD’ers?
Last month the FDA (Food and Drug Administration) voted unanimously that the benefit of Advair and Symbicort outweighed the risks of... Read more »
Understanding Black Box Warnings for Asthma Medicines
Some of the most effective asthma medicines are inhaled steroids, and the downside to this is that the word "steroid" has a bad reputation.... Read more »
Serevent and Foradil carry more risks, and benefits, than other...
In this entry, I would like to discuss some recent findings on two similar medications that have significantly changed the landscape of... Read more »
Advair and Symbicort: “Benefits Outweigh Risk” says an FDA...
Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
Don't be Afraid of Using Advair and Symbicort
So what's the deal with Advair and Symbicort? These meds have helped so many asthmatics finally gain control of their asthma, yet, with... Read more »
From Our Sources
Clinical trial: Asthma and genetics in patients using Advair o...
This is a study sponsored by GlaxoSmithKline to determine the relationship between asthma and genetics in patients using Advair and Serevent. This... Read more »
Clinical trial: Advair vs. Serevent in patients of African des...
GlaxoSmithKline is conducting a clinical trial to see if fluticasone propionate plus salmeterol (Advair) is better than fluticase propionate alone... Read more »
FDA warned on risks associated with 4 asthma inhalers
The U.S. Food and Drug Administration (FDA) is again concerned about the safety of four popular asthma inhalers. Two federal safety officials wrote... Read more »
FDA panel says Serevent, Foradil too risky for asthmatics
A U.S. Food and Drug Administration (FDA) advisory panel says that asthma and COPD drugs Advair and Symbicort are safe for use, but Serevent and... Read more »
Advair, Symbicort and FDA Advisory Committee Recommednations f...
Have questions or comments? Click here. Last week the Food and Drug Administration (FDA) listened to presentations and comments from several members... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
